Clinical Trial Update: A Randomized Phase II Study Evaluating Upfront SRT to All Brain Metastases Followed by Ivonescimab Plus Chemotherapy Versus Upfront Ivonescimab Plus Chemotherapy in Patients With Asymptomatic Active Brain Metastases From NSCLC [Phase 2]

View source ↗

Summary

A randomized Phase II trial evaluates upfront stereotactic radiotherapy to all brain metastases followed by Ivonescimab plus chemotherapy versus upfront Ivonesc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING